GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMF) » Definitions » Net Margin %

NVZMF (Novonesis (Novozymes) B) Net Margin % : 12.08% (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Novonesis (Novozymes) B's Net Income for the three months ended in Dec. 2024 was $253 Mil. Novonesis (Novozymes) B's Revenue for the three months ended in Dec. 2024 was $2,096 Mil. Therefore, Novonesis (Novozymes) B's net margin for the quarter that ended in Dec. 2024 was 12.08%.

The historical rank and industry rank for Novonesis (Novozymes) B's Net Margin % or its related term are showing as below:

NVZMF' s Net Margin % Range Over the Past 10 Years
Min: 7.98   Med: 20.99   Max: 22.42
Current: 12.08


NVZMF's Net Margin % is ranked better than
83.64% of 1534 companies
in the Chemicals industry
Industry Median: 3.995 vs NVZMF: 12.08

Novonesis (Novozymes) B Net Margin % Historical Data

The historical data trend for Novonesis (Novozymes) B's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Net Margin % Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.16 21.04 20.94 16.90 7.98

Novonesis (Novozymes) B Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.37 21.01 18.05 - 12.08

Competitive Comparison of Novonesis (Novozymes) B's Net Margin %

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Net Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Net Margin % distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Net Margin % falls into.


;
;

Novonesis (Novozymes) B Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Novonesis (Novozymes) B's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=320.209/4014.136
=7.98 %

Novonesis (Novozymes) B's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=253.298/2096.126
=12.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis (Novozymes) B  (OTCPK:NVZMF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Novonesis (Novozymes) B Net Margin % Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

From GuruFocus

Novozymes A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2020 Novozymes A/S Trading Update Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novozymes A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024